- 2023 - 2026 中性グルコシルセラミド分解酵素を介した神経変性疾患発症機構の解明
- 2023 - 2024 パーキンソン病関連新規脳内糖脂質の分析基盤の構築
- 2022 - 2024 グルコシルセラミド分解酵素を介したパーキンソン病発症機構の解明
- 2018 - 2021 Investigating the pathogenesis and development of therapeutics of alpha-synucleinopathy
- 2017 - 2020 Development of an analytical platform for novel brain glycosylated sterols toward applying for the treatment of neurodegenerative diseases
- 2018 - 2019 Development of a histochemical analytical system for metabolic enzymes of novel brain glycosylated sterols
- 2015 - 2018 Unveiling the Pathological Mechanisms and Developing New Treatment of Parkinsons Disease Caused by GBA1 Mutations
- 2015 - 2017 Development of glycosylated lipid metabolomics system for clarifying their neuronal function
- 2014 - 2017 Parkinson's disease pathogenesis mediated by glycosylation of cholesterol
- 2015 - 2016 パーキンソン病発症因子・グルコシルセラミド分解酵素GBA1の新規脂質代謝産物の発見と機能解析
Show all